2019 American Transplant Congress
Clinical Outcomes of Patients with Portal Vein Tumor Thrombi after Living Donor Liver Transplantation
Surgery, Seoul St. Mary's Hospital, Catholic University of Korea, Seoul, Korea, Republic of
*Purpose: Patient selection criteria for living donor liver transplantation(LDLT) with hepatocellular carcinoma are generally wider than those for deceased donor liver transplantation. It is widely…2019 American Transplant Congress
Kidney Transplant Outcome between Identical Twins in USA from 2001-2017
Starzl Transplant Institute, Univ of Pittsburgh Med Center, Pittsburgh, PA
*Purpose: This study provides the outcome of Identical-Twin (IT) Kidney-Transplants (KT) in the USA.*Methods: The data from U.S. Census Bureau, National Center for Health Statistics,…2019 American Transplant Congress
Clinical Features of IgA Nephropathy Recurrence after Kidney Transplantation
*Purpose: Recurrence of IgA nephropathy (IgAN) is one of the major cause of kidney graft loss. The clinical features of disease recurrence after kidney transplantation…2019 American Transplant Congress
Outcome of Renal Transplantation in Systemic Amyloidosis
*Purpose: Systemic amyloidosis accounts for approximately 0.8% of end stage renal disease (ESRD) in the UK. Outcomes following renal transplantation in systemic amyloidosis were historically…2019 American Transplant Congress
Prevalence of Recurrent and De Novo Glomerular Diseases after Renal Transplantation: A Single Center Experience
Montefiore-Einstein Transplant Center, Scarsdale, NY
*Purpose: Recurrent and de novo glomerular diseases documented to develop in 10-15% of kidney transplant recipients and are the third leading cause of allograft loss.…2019 American Transplant Congress
Mesangiopathic Glomerulonephritis in Kidney Transplants
*Purpose: Describe higher than anticipated prevalence of Mesangiopathic Glomerulonephritis on surveillance biopsies.*Methods: Review of all surveillance biopsies from September 2014 through September 2018 for presence…2019 American Transplant Congress
Development of a Recurrence Risk Score in IgA Nephropathy after Kidney Transplantation: Role of Recipient Age and HLA-B Mismatch
*Purpose: Recurrence of IgA nephropathy is an important and growing cause of kidney allograft dysfunction. The purpose of this observational retrospective study was to characterize…2019 American Transplant Congress
Peri-Operative Basiliximab is Not Associated with Post-Transplant Hepatocellular Carcinoma Recurrence in Liver Transplant Recipients
*Purpose: The optimal immunosuppression for liver transplant recipients (LTR) with hepatocellular carcinoma (HCC) is unknown. Basiliximab, an interleukin-2 receptor antagonist (IL-2RA), confers immunosuppression for LTR…2019 American Transplant Congress
The Evolution of Body Mass Index after Kidney Transplantation in Recipients with a Previous Laparoscopic Sleeve Gastrectomy
Universite de Montreal, Hopital Maisonneuve-Rosemont, Montreal, QC, Canada
*Purpose: Bariatric surgery is one of the most common operations. Laparoscopic sleeve gastrectomy (LSG) has been reported to prepare candidates for listing. However, weight gain…2019 American Transplant Congress
Impact of Everolimus on Secondary Nonmelanoma Skin Cancer Prevention in Solid Organ Transplant Recipients
*Purpose: Over half of solid organ transplant recipients (SOTR) develop nonmelanoma skin cancers (NMSC) and up to 80% experience recurrence. Many immunosuppressive drugs are known…
American Transplant Congress abstracts